
- /
- Supported exchanges
- / DU
- / RHO.DU
ROCHE HLDG - Dusseldorf Stock Exchang (RHO DU) stock market data APIs
ROCHE HLDG - Dusseldorf Stock Exchang Financial Data Overview
There is no Profile data available for RHO.DU.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get ROCHE HLDG - Dusseldorf Stock Exchang data using free add-ons & libraries
Get ROCHE HLDG - Dusseldorf Stock Exchang Fundamental Data
ROCHE HLDG - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get ROCHE HLDG - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ROCHE HLDG - Dusseldorf Stock Exchang News

Parse-Enabled Study Maps Neuronal Pathways with Potential Implications for Neurodegenerative Disease Research
SEATTLE, July 10, 2025--(BUSINESS WIRE)--Parse Biosciences, the leading provider of accessible and scalable single cell sequencing solutions, today announced a groundbreaking study published in the jo...


Diagnostics Transformed: $37 Billion Immunoassay Market Evolves with AI, Miniaturization, and POC Growth, reports Kalorama Information
ARLINGTON, Va., July 10, 2025 /PRNewswire/ -- Kalorama Information, a leading healthcare market intelligence firm, has published a comprehensive new report, Global Immunoassay Market: Trends, Technolo...

Danon Disease Treatment Modality Market Analysis and Forecasts 2025-2035 | Next-Gen Sequencing Speeds Up Danon Disease Diagnosis and Treatment Pathways
Company Logo Danon disease, a rare X-linked dominant disorder due to LAMP2 gene mutations, primarily affects males, causing cardiomyopathy, skeletal myopathy, and cognitive issues. Advancements in NG...

Pharma Companies Remain Calm Amid Fresh Tariff Threat by Trump
And the tariff threat is back. President Trump has once again threatened to impose heavy tariffs on pharmaceutical imports that will possibly be implemented after a year and a half. Nonetheless, the m...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.